Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis.
- 1 November 1994
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 24 (5) , 538-548
- https://doi.org/10.1161/01.hyp.24.5.538
Abstract
Recent studies have revealed that angiotensin II (Ang II) interacts with two pharmacologically different types of seven-transmembrane domain receptors, hence named Ang II type 1 and type 2 (AT1 and AT2) receptors. cDNAs for the AT1 receptor have been cloned, and the existence of two receptor subtypes, AT1A and AT1B, has been revealed in rat and mouse. This study presents a new approach for the specific quantification of AT1A and AT1B receptor mRNAs by reverse transcription and polymerase chain reaction amplification in the presence of an AT1 receptor mutant cRNA as internal standard. Absolute quantities of mRNA are then determined by extrapolation using the standard curve generated with the internal standard. Moreover, addition of this internal standard to each tube controls for both reverse transcription and polymerase chain reaction amplification in each sample. In male Wistar rats, the highest absolute AT1A receptor mRNA levels were found in liver and kidney and those for AT1B receptor mRNA in the pituitary. Expressed as a percentage of total AT1A+AT1B receptor mRNA content, AT1A receptor mRNA content was 100% in liver, 85% in lung, 73% in kidney, 65% in aorta, 48% in adrenals, and 15% in the hypophysis. Since this approach can determine absolute AT1A and AT1B receptor mRNA quantities in different organs, it allows the study of the regulation of their expression under different pathophysiological conditions. After sodium depletion, known to induce hyperactivity of the renin-angiotensin system, adrenal AT1A and AT1B receptor mRNA levels were increased by 60% and 110%, respectively. In contrast, in renovascular hypertension (two-kidney, one clip), also associated with elevated circulating plasma renin activity, adrenal AT1B receptor mRNA levels decreased by 50%, whereas there was no change in those of AT1A. Therefore, the differential distribution and regulation of these two receptor subtypes suggest that each of them might be involved in the mediation of different biological effects of Ang II.Keywords
This publication has 42 references indexed in Scilit:
- Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the ratBiochemical and Biophysical Research Communications, 1992
- Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human)Biochemical and Biophysical Research Communications, 1992
- Differential expression of angiotensin II receptor subtype mRNAs (AT-1A and AT-1B) in the brainBiochemical and Biophysical Research Communications, 1992
- Isolation of two distinct type I angiotensin II receptor genesBiochemical and Biophysical Research Communications, 1992
- Angiotensin II type-1 receptor subtype cDNAs: Differential tissue expression and hormonal regulationBiochemical and Biophysical Research Communications, 1992
- Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptorBiochemical and Biophysical Research Communications, 1992
- Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptorBiochemical and Biophysical Research Communications, 1992
- Angiotensin receptor subtypes in rat, rabbit and monkey tissues: Relative distribution and species dependencyLife Sciences, 1991
- Rat angiotensin II receptor: cDNA sequence and regulation of the gene expressionBiochemical and Biophysical Research Communications, 1991
- Preliminary biochemical characterization of two angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989